Nestlé Health Science, a subsidiary of Switzerland-based chocolate company Nestlé launched at the start of the year, will buy specialty pharmaceutical and diagnostic company Prometheus Laboratories for an undisclosed amount.

Luis Cantarell, executive president of Nestlé Health Science, said: "This is a strategic move into gastrointestinal diagnostics. Prometheus’s leading edge diagnostics technology and outstanding sales force will help us to develop an integrated approach to personalized healthcare.

"It is fully consistent with our vision of pioneering science-based nutritional solutions…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?